Government of CanadaPublic Health Agency of Canada / Agency de la santé publique du Canada
   
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m  
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors HealthSurveillance Health Canada
   
    Public Health Agency of Canada (PHAC)
Canada Communicable Disease Report

[Table of Contents]

 

 

Volume: 23S7 - November 1997

CONTROLLING ANTIMICROBIAL RESISTANCE
An Integrated Action Plan for Canadians


Appendix VI AGENDA

Wednesday, May 28, 1997

 

Chairperson - Dr. Michel Brazeau

14:00

Opening remarks
Ms. Michèle S. Jean, Deputy Minister, Health Canada
Dr. John Conly, Canadian Infectious Disease Society
Ms. Shirley Paton, LCDC, Health Canada

14:15

Comments from the Chair
Dr. Michel Brazeau, Fédération des médecins spécialistes du Québec

14:25

I. CURRENT STATUS OF ANTIMICROBIAL RESISTANCE

Antimicrobial Resistance: an Overview
Dr. John McGowan Jr, Emory University

Antimicrobial Resistance: a Canadian Perspective
Dr. Donald Low, Mount Sinai and Princess Margaret Hospitals

Controlling Antimicrobial Resistance: Denmark's Success Story
Dr. Henrik Westh, Statens Serum Institut

Dr. Thomas Lund Soerensen, Statens Serum Institut

Role of the Laboratory in Detecting Antimicrobial Resistance
Dr. Kevin Forward, Canadian Association of Medical Microbiologists

Issues in Surveillance
Dr. Paul Sockett, LCDC, Health Canada

Question period

16:00

II. CURRENT STATUS OF ANTIMICROBIAL AGENTS

Use of Antimicrobial Agents in Agricultural Settings
Dr. John Prescott, Ontario Veterinary College

Use of Antimicrobial Agents in Humans
Dr. Robert Coambs, University of Toronto

Public Perception of the Use of Antimicrobial Agents
Dr. Ben Schwartz, National Center for Infectious Diseases, CDC

Developing New Drugs
Mr. Gregory Hines, Pharmaceutical Manufacturers Association of Canada

Question period

16:45

III. STRATEGIES TO PREVENT AND CONTROL ANTIMICROBIAL RESISTANCE

Preventing the Transmission of Infectious Organisms
Dr. Lindsay Nicolle, University of Manitoba

Use of Vaccines to Prevent Infections
Dr. David Scheifele, B.C. Vaccine Evaluation Centre

Principles of Quality Improvement Strategies
Ms. Anu MacIntosh, Hospital for Sick Children

Application of Quality Improvement Strategies to Control Resistance

Dr. John Conly, Canadian Infectious Disease Society

Question period

17:45

DINNER - Salle de Bal Ouest

19:00

IV. CHANGING PEOPLE'S BEHAVIOUR

Theory and Principles of Behaviour Change
Dr. Joy Johnson, University of British Columbia

Do Guidelines Work?
Dr. Anne Carter, Canadian Medical Association

Risk and Risk Perception
Dr. David Paltiel, Yale University

Using the Media to Communicate Ideas
Dr. Douglas Powell, University of Guelph

Ethics: The Clash of Principles and Life
Professor Wendy Mariner, Boston University

Question period

20:15

Adjourn

Thursday, May 29, 1997

 

Chairperson - Dr. Michel Brazeau

08:15

Directions for working groups

08:30

Small working groups

10:00

Refreshment break

10:20

Small working groups

12:00

LUNCH - Salle de Bal Ouest

13:15

Larger working groups

15:00

Refreshment break

15:15

Larger working groups

17:30

DINNER- Salle de Bal Ouest

18:45

Complete consensus of larger working groups

20:15

Adjourn

Friday, May 30, 1997

Chairperson - Dr. Michel Brazeau

08:30

Presentation of reports by working groups

10:30

Refreshment break

11:00

Consensus building

12:30

Working lunch

13:10

Consensus building

15:15

Closing remarks

Dr. Joseph Losos, Assistant Deputy Minister, Health Protection Branch, Health Canada

15:30

Adjournment

 

[Previous] [Table of Contents]

Last Updated: 2002-11-08 Top